Skip to main content
Tammy Wichman, MD, Pulmonology, Omaha, NE

TammyJWichmanMD

Pulmonology • Omaha, NE

Critical Care Medicine, Pleural Disease

Associate Professor of Medicine University of Nebraska School of Medicine

Join to view full profile

Dr. Wichman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wichman's full profile

Already have an account?

  • Office

    Emile 42nd St
    Omaha, NE 68198
    Phone+1 402-559-4015
    Fax+1 402-559-8715

Education & Training

  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 2003
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Internal Medicine/Pediatrics, 1996 - 2000
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 1996

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2003 - 2026
  • VA State Medical License
    VA State Medical License 1998 - 2004
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ‘Health Care Works Are Exhausted,’ UNMC Letter Receives 2k+ Signatures
    ‘Health Care Works Are Exhausted,’ UNMC Letter Receives 2k+ SignaturesNovember 18th, 2020
  • Targeted Therapy with Phosphodiesterase 5 Inhibitors in Patients with Pulmonary Hypertension Due to Heart Failure and Elevated Pulmonary Vascular Resistance: A Systematic Review
    Targeted Therapy with Phosphodiesterase 5 Inhibitors in Patients with Pulmonary Hypertension Due to Heart Failure and Elevated Pulmonary Vascular Resistance: A Systematic ReviewOctober 7th, 2020

Dr. Tammy Wichman, Dr. Tammy Wichman, MD, Dr. T Wichman, Dr. Tammy J Wichman